← Leaderboards
Jennifer A Philips
Washington University
$15,162,669
Attributed
$15,162,669
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,162,669 · 9
By mechanism
R01$13,103,895 · 4
R21$1,730,438 · 4
K08$328,336 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Daniel S Ory$14,176,962
- Kwee Liu Lin Thio$1,634,886
- Peter A Crawford$19,489,388
- Antonina I Frolova$1,470,036
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisMacrophageTuberculosisInfectionInsightBacteriaTraffickingPlayCellsMutantPreventProteinsPathway InteractionsPathogenIn VivoNovel TherapeuticsVaccinesImmunityPhagosomesImmuneAntimicrobialImpairmentMycobacterialGrowth
Grant awards (39)
Understanding early macrophage-T cell interactions, SLAMF1, and immunity to TB$772,420
R01 · FY2025 · AI · contact PI
Defining host-pathogen oxysterol co-metabolites and their role in TB pathogenesis$647,402
R01 · FY2025 · AI · contact PI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis$590,755
R01 · FY2025 · AI · contact PI
How Mtb 3B-hydroxysteroid dehydrogenase accesses host cholesterol$67,754
R01 · FY2025 · AI · contact PI
Understanding early macrophage-T cell interactions, SLAMF1, and immunity to TB$772,420
R01 · FY2024 · AI · contact PI
Defining host-pathogen oxysterol co-metabolites and their role in TB pathogenesis$652,582
R01 · FY2024 · AI · contact PI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis$609,027
R01 · FY2024 · AI · contact PI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis$656,517
R01 · FY2023 · AI · contact PI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis$660,713
R01 · FY2022 · AI · contact PI
ROLE OF ESXG-ESXH IN MYCOBACTERIUM TUBERCULOSIS PATHOGENESIS$417,287
R01 · FY2022 · AI · contact PI
Cholesterol oxidation products in TB pathogenesis and as biomarkers of disease$196,875
R21 · FY2022 · AI · contact PI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis$544,535
R01 · FY2021 · AI · contact PI
ROLE OF ESXG-ESXH IN MYCOBACTERIUM TUBERCULOSIS PATHOGENESIS$426,149
R01 · FY2021 · AI · contact PI
Cholesterol oxidation products in TB pathogenesis and as biomarkers of disease$236,250
R21 · FY2021 · AI · contact PI
The Role of SLAMF1 in TB Immunity$196,875
R21 · FY2021 · AI · contact PI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis$544,535
R01 · FY2020 · AI · contact PI
ROLE OF ESXG-ESXH IN MYCOBACTERIUM TUBERCULOSIS PATHOGENESIS$469,186
R01 · FY2020 · AI · contact PI
The Role of SLAMF1 in TB Immunity$236,188
R21 · FY2020 · AI · contact PI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis$544,535
R01 · FY2019 · AI · contact PI
ROLE OF ESXG-ESXH IN MYCOBACTERIUM TUBERCULOSIS PATHOGENESIS$516,265
R01 · FY2019 · AI · contact PI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis$567,384
R01 · FY2018 · AI · contact PI
ROLE OF ESXG-ESXH IN MYCOBACTERIUM TUBERCULOSIS PATHOGENESIS$455,830
R01 · FY2018 · AI · contact PI
Targeting Fatty Acid Metabolism to Treat TB$190,625
R21 · FY2018 · AI · contact PI
ROLE OF ESXG-ESXH IN MYCOBACTERIUM TUBERCULOSIS PATHOGENESIS$35,586
R01 · FY2018 · AI · contact PI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis$552,134
R01 · FY2017 · AI · contact PI
Targeting Fatty Acid Metabolism to Treat TB$228,750
R21 · FY2017 · AI · contact PI
THE ROLE OF ESCRT IN MACROPHAGE RESISTANCE TO MYCOBACTERIA$381,250
R01 · FY2016 · AI · contact PI
THE ROLE OF ESCRT IN MACROPHAGE RESISTANCE TO MYCOBACTERIA$381,250
R01 · FY2015 · AI · contact PI
THE ROLE OF UBIQUILINS IN INNATE IMMUNITY TO TUBERCULOSIS$190,625
R21 · FY2015 · AI · contact PI
THE ROLE OF UBIQUILINS IN INNATE IMMUNITY TO TUBERCULOSIS$254,250
R21 · FY2014 · AI · contact PI
The Role of ESCRT in Macrophage Resistance to Mycobacteria$89,549
R01 · FY2014 · AI · contact PI
The Role of ESCRT in Macrophage Resistance to Mycobacteria$516,539
R01 · FY2013 · AI · contact PI
The Role of ESCRT in Macrophage Resistance to Mycobacteria$397,150
R01 · FY2013 · AI · contact PI
The Role of ESCRT in Macrophage Resistance to Mycobacteria$32,391
R01 · FY2013 · AI · contact PI
The Role of ESCRT in Macrophage Resistance to Mycobacteria$422,500
R01 · FY2012 · AI · contact PI
The Role of ESCRT in Macrophage Resistance to Mycobacteria$380,250
R01 · FY2011 · AI · contact PI
Innate Immune Responses to Mycobacteria$79,632
K08 · FY2006 · AI · contact PI
Innate Immune Responses to Mycobacteria$124,632
K08 · FY2005 · AI
Innate Immune Responses to Mycobacteria$124,072
K08 · FY2004 · AI